Is 90 the new 80? Temporal trends in nonagenarians undergoing percutaneous coronary interventions.

Ori Rahat, Mark Kheifets, Tamir Bental, Shelly Abigail Vons, Ori Tishler, Tsahi T Lerman, Caroline Kaufman, Leor Perl, Gabriel Greenberg, Pablo Codner, Guy Witberg, Hana Vaknin-Assa, Ran Kornowski, Amos Levi
{"title":"Is 90 the new 80? Temporal trends in nonagenarians undergoing percutaneous coronary interventions.","authors":"Ori Rahat, Mark Kheifets, Tamir Bental, Shelly Abigail Vons, Ori Tishler, Tsahi T Lerman, Caroline Kaufman, Leor Perl, Gabriel Greenberg, Pablo Codner, Guy Witberg, Hana Vaknin-Assa, Ran Kornowski, Amos Levi","doi":"10.1016/j.amjms.2024.06.029","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Coronary artery disease (CAD) is a leading cause of death in the elderly population. Data regarding percutaneous coronary interventions (PCIs) in nonagenarians are scarce, and differences in long term outcomes between generations remain unclear. We aimed to study the pattern and temporal trends of nonagenarians treated with PCI.</p><p><strong>Materials and methods: </strong>A total of 14,695 patients underwent PCI between 2009-2020. We identified 2,034 (13.8%) octogenarians (age 80-89), and 222 (1.5%) nonagenarians (age 90-99). Endpoints included mortality and major adverse cardiac events (MACE) at 1 year.</p><p><strong>Materials and methods: </strong>A total of 14,695 patients underwent PCI between 2009-2020. We identified 2,034 (13.8%) octogenarians (age 80-89), and 222 (1.5%) nonagenarians (age 90-99). Endpoints included mortality and major adverse cardiac events (MACE) at 1 year.</p><p><strong>Results: </strong>The number of nonagenarians undergoing PCI has increased substantially during the study time period, from 89 patients in the earlier time period (2009-2014) to 133 patients in the later time period (2015-2020). At 1-year, nonagenarians had significantly higher rates of both death (24.3% vs. 14.9%, p<0.01), and MACE (30.6% vs. 22.0%, p<0.01), as compared to octogenarians. The cumulative survival rate was higher among octogenarians both in the early and late time period (p<0.01 and p=0.039, respectively). A significant reduction in nonagenarian MACE rates were observed during the study time period, resulting in a non-significant difference in MACE rates in the later time period between both groups.</p><p><strong>Conclusion: </strong>The number of nonagenarians who undergo PCI is on the rise. While their clinical outcomes are inferior as compared to younger age groups, improvement was noted in the late time period.</p>","PeriodicalId":94223,"journal":{"name":"The American journal of the medical sciences","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American journal of the medical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.amjms.2024.06.029","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Coronary artery disease (CAD) is a leading cause of death in the elderly population. Data regarding percutaneous coronary interventions (PCIs) in nonagenarians are scarce, and differences in long term outcomes between generations remain unclear. We aimed to study the pattern and temporal trends of nonagenarians treated with PCI.

Materials and methods: A total of 14,695 patients underwent PCI between 2009-2020. We identified 2,034 (13.8%) octogenarians (age 80-89), and 222 (1.5%) nonagenarians (age 90-99). Endpoints included mortality and major adverse cardiac events (MACE) at 1 year.

Materials and methods: A total of 14,695 patients underwent PCI between 2009-2020. We identified 2,034 (13.8%) octogenarians (age 80-89), and 222 (1.5%) nonagenarians (age 90-99). Endpoints included mortality and major adverse cardiac events (MACE) at 1 year.

Results: The number of nonagenarians undergoing PCI has increased substantially during the study time period, from 89 patients in the earlier time period (2009-2014) to 133 patients in the later time period (2015-2020). At 1-year, nonagenarians had significantly higher rates of both death (24.3% vs. 14.9%, p<0.01), and MACE (30.6% vs. 22.0%, p<0.01), as compared to octogenarians. The cumulative survival rate was higher among octogenarians both in the early and late time period (p<0.01 and p=0.039, respectively). A significant reduction in nonagenarian MACE rates were observed during the study time period, resulting in a non-significant difference in MACE rates in the later time period between both groups.

Conclusion: The number of nonagenarians who undergo PCI is on the rise. While their clinical outcomes are inferior as compared to younger age groups, improvement was noted in the late time period.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
90 岁是新的 80 岁吗?接受经皮冠状动脉介入治疗的非老年患者的时间趋势。
背景:冠状动脉疾病(CAD)是导致老年人死亡的主要原因。有关非老年人经皮冠状动脉介入治疗(PCI)的数据很少,不同年龄段之间的长期疗效差异仍不清楚。我们旨在研究接受 PCI 治疗的非老年患者的模式和时间趋势:2009-2020年间,共有14695名患者接受了PCI治疗。我们确定了 2034 名(13.8%)八旬老人(80-89 岁)和 222 名(1.5%)非耄耋老人(90-99 岁)。终点包括1年的死亡率和主要心脏不良事件(MACE):在研究期间,接受PCI治疗的非老年患者人数大幅增加,从早期(2009-2014年)的89人增加到后期(2015-2020年)的133人。1年后,非长者的死亡率明显高于长者(24.3% vs. 14.9%,pConclusion):接受PCI治疗的非长者人数正在增加。虽然他们的临床结果不如年轻群体,但在晚期有所改善。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Identification and validation of leukemia inhibitory factor as a protective factor in ischemic acute kidney injury. miRNA-105-5p Regulates the Histone Deacetylase HDAC2 through FOXG1 to Affect the Malignant Biological Behavior of Triple-negative Breast Cancer Cells. Lung Transplant Access Disparities for Asian Patients with Idiopathic Pulmonary Fibrosis. Uncontrolled Anger: A Fuel for Cardiovascular Disease? Pleural Complications in Patients with Renal Cell Carcinoma Undergoing Percutaneous Cryoablation: A Retrospective Analysis of its Incidence and Risk Factors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1